Concepedia

Author

Gábor Kovács

Semmelweis UniversityORCID

Also Known As

G KOVACS, G Kovacs, G Kovács, G T Kovacs, G T Kovács, G. Kovacs, G. Kovács, G. T. Kovács, G.T. Kovacs, G.T. Kovács

220

Publications

4.8K

Citations

36

H-Index

114

Concepts

All Affiliations

Semmelweis UniversityHeim Pál Országos Gyermekgyógyászati IntézetHungarian Academy of SciencesBudapest University of Technology and EconomicsUniversity of Pecs
GK

About

Gábor Kovács is an author at Semmelweis University specializing in medicine, public health, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

37

1.8K

2

Public Health

12

12

468

3

Health Sciences

4

4

96

4

Social Sciences

2

2

48

5

Biomedical Engineering

1

1

20

Gábor Kovács

×

70

Publications

4.2K

Citations

32

H-Index

YearCitations

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial

Kirsten Fischer, Jasmin Bahlo, Anna Maria Fink,

Blood

2015

693

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

Barbara Eichhorst, Anna‐Maria Fink, Jasmin Bahlo,

The Lancet Oncology

2016

613

Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002

Jan Starý, Martin Zimmermann, Myriam Campbell,

Journal of Clinical Oncology

2013

335

Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group

Gábor Kovács, Sandra Robrecht, Anna Maria Fink,

Journal of Clinical Oncology

2016

170

Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

Barbara Eichhorst, Anna Maria Fink, Raymonde Busch,

Blood

2014

117

The Investigation of Idiopathic Infertility by in Vitro Fertilization

Alan Trounson, John Leeton, Carl Wood,

Fertility and Sterility

1980

115

<i>ABCC1</i> polymorphisms in anthracycline‐induced cardiotoxicity in childhood acute lymphoblastic leukaemia

Ágnes F. Semsei, Dániel J. Erdélyi, Ildikó Ungvári,

Cell Biology International

2011

112

Laparoscopic Replacement of Urinary Tract Segments Using Biodegradable Materials in a Large-Animal Model

Arieh L. Shalhav, ABDELHAMID M. ELBAHNASY, EDUARDO BERCOWSKY,

Journal of Endourology

1999

87

Good prognosis of localized osteosarcoma in young patients treated with limb‐salvage surgery and chemotherapy

Márta Hegyi, Ágnes F. Semsei, Zsuzsanna Jakab,

Pediatric Blood & Cancer

2011

82

Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Acute Lymphoblastic Leukemia Intercontinental-Berlin-Frankfurt-Münster 2009 Trial

Myriam Campbell, Csongor Kiss, Martin Zimmermann,

Journal of Clinical Oncology

2023

74

Page 1